Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Rachel O'Donnell

Newcastle AuthorsTitleYearFull text
Ali Kucukmetin
Dr Nicola Cresti
Dr Rachel O'Donnell
BRAF Wild-type, PTEN Mutant Malignant Uveal Melanoma Arising Within a Mature Ovarian Teratoma: A Case Report and Review of the Literature2019
Lucy Gentles
Bojidar Goranov
Elizabeth Matheson
Dr Ashleigh Herriott
Dr Angelika Kaufmann
et al.		Exploring the frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types2019
Dr Rachel O'Donnell
Impact of surgical site infection (SSI) following gynaecological cancer surgery in the United Kingdom: A trainee-led multicentre audit and service evaluation2019
Dr Rachel O'Donnell
Borderline Ovarian Tumors: Fifteen Years’ Experience at a Scottish Tertiary Cancer Center2018
Lucy Gentles
Liz Matheson
Dr Nicholas Bown
Alice Bradbury
Maryam Zanjirband Zanjirband
et al.		Characterization and drug sensitivity of a novel human overian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor2018
Lucy Gentles
Dr Calum Kirk
Huw Thomas
Professor Steve Wedge
Professor Nicola Curtin
et al.		An investigation of the effect of tissue ischaemia upon DNA damage protein markers in ovarian cancer2017
Dr Aiste McCormick
Gavin Cuthbert
Dr Rachel O'Donnell
Dr Brian Wilson
Huw Thomas
et al.		Functional characterisation of a novel ovarian cancer cell line, NUOC-12017
Dr Rachel O'Donnell
Dr Ann Fisher
Locally advanced vulva cancer: A single centre review of anovulvectomy and a systematic review of surgical, chemotherapy and radiotherapy alternatives. Is an international collaborative RCT destined for the “too difficult to do” box?2017
Dr Aiste McCormick
Dr Peter Donoghue
Michelle Dixon
Dr Rachel O'Donnell
James Murray
et al.		Ovarian Cancers Harbour Defects in Non-Homologous End Joining Resulting in Resistance to Rucaparib2017
Dr Rachel O'Donnell
Dr Angelika Kaufmann
Dr Laura Woodhouse
Dr Aiste McCormick
Professor Richard Edmondson
et al.		Advanced Ovarian Cancer Displays Functional Intratumor Heterogeneity That Correlates to Ex Vivo Drug Sensitivity2016
123